Drug · DIN 02420376
JUXTAPID
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 23, 2024; first marketed May 6, 2014.
- Drug Identification Number (DIN)
- 02420376
- Company (DIN owner)
- Chiesi Farmaceutici S.P.A.Parma, --, Italy
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lomitapide C10AX12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LOMITAPIDE (LOMITAPIDE MESYLATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 23, 2024: NOC 32764New Drug Submission (NDS) · Administrative: Change in Product Ownership
- April 29, 2022: NOC 28071New Drug Submission (NDS) · Administrative: Change in Product Ownership
- February 4, 2014: NOC 15198New Drug Submission (NDS)
Other DINs named JUXTAPID
- DIN 02420341 · Marketed
- DIN 02420384 · Marketed